Reviews

No reviews yet. Be the first to review P6006.

Requisite map

Overview

The Master of Global Medicines Development is a joint degree offered by Monash University and The University of North Carolina at Chapel Hill. This program provides you with a comprehensive understanding of how the discovery, development, and distribution of new medicines unfold on a global scale. In the units, taught collaboratively by academics across the two institutions, you will confront pressing issues such as funding medicines development in developing countries, navigating global drug regulations, and addressing disparities in access to appropriate medicines. By engaging with academics and your peers from around the world, you will develop leadership, data and financial management skills, and the cross-cultural understanding needed to work effectively in diverse teams. Through interdisciplinary coursework, team-based projects and a final semester placement opportunity, you will develop the expertise required to tackle pressing global challenges in the development of new medicines.

Course structure

Part A. Core studies42 credit points

You must complete the following units

Part B. Specified elective studies6 credit points

You must complete one of the following units

GMD5005Global medicines development: Emerging topics in regulatory scienceNo reviews yet6 cp

GMD5006 Global medicines development: Post marketing topics (not available in 2026)

6 credit points

The content for this unit is under development.

GMD5007 Global medicines development: Chemistry, manufacturing, and controls (not available in 2026)

6 credit points

The content for this unit is under development.

Part C. Professional practice24 credit points

You must complete the following unit

GMD5004 Professional placement and global research project

24 credit points

The content for this unit is under development.

The handbook's description of this structure

The course is structured in three parts: Part A: Core studies; Part B: Specified elective studies; Part C: Professional Practice

Part A. Core studies

This part of the course covers core topics that provide the foundational knowledge in pharmaceutical sciences underpinning the discovery, development and regulation of medicines in a sustainable and socially responsible context. You will also develop leadership, financial and data management, and other related skills to help you to prepare for professional placement, and to effect meaningful change in the global medicines development landscape.

Part B. Specified elective studies

In this part of the course, you will be able to select an elective unit to extend your knowledge in regulatory science, post-marketing or manufacturing and controls.

Part C. Professional practice

In this part of the course, you will undertake a professional placement in the pharmaceutical or related industries, or in a research laboratory, giving you the opportunity to apply your knowledge and skills to solve contemporary problems in medicines development of global significance in a workplace setting. To accompany your industry experience and demonstrate mastery of course learning outcomes, you will complete a capstone project, related to the work you complete on your professional placement.

Course progression map

The course progression map will provide guidance on unit enrolment for each semester of study.

The course comprises 72 points structured into three parts: Part A: Core studies (42 points), Part B: Specified elective studies (6 points) and Part C. Professional practice (24 points).

Units are 6 points unless otherwise stated.

Part A. Core studies (42 points)

You must complete the following units:

MPS5101 Overview of drug discovery and development
MPS5201 Drug stories: Lessons from the past and now
MPS5202 From ideas to medicines: Investigator perspectives
MPS5303 Career tools: Bridging the gap
GMD5001 Global medicines development: Fundamentals of regulatory affairs
GMD5002 Global leadership in pharmaceutical sciences
GMD5003 Financial and data management in global medicines development

Part B: Specified elective studies (6 points)

You must complete 6 credit points (one unit) from the the following list of units:

GMD5005 Global medicines development: Emerging topics in regulatory science
GMD5006 Global medicines development: Post marketing topics (not available in 2026)
GMD5007 Global medicines development: Chemistry, manufacturing, and controls (not available in 2026)

Part C. Professional practice (24 points)

You must complete the following unit:

GMD5004 Professional placement and global research project

Learning outcomes

These course outcomes are aligned with the Australian Qualifications Framework and Monash Graduate Attributes.

Upon successful completion of this course it is expected that you will be able to:

1
synthesise and communicate the principles and application of pharmaceutical science in the discovery, development, formulation and distribution of medicines, in a global context;
2
demonstrate skills and integrated understanding of cutting-edge technologies required to solve global problems in medicines discovery and development;
3
apply methods of data science to critically analyse, synthesise and communicate data related to global medicines development;
4
demonstrate advanced and integrated understanding of a specific subdiscipline of pharmaceutical science, such as drug discovery, product formulation, clinical development or regulatory affairs;
5
critically analyse, reflect on and synthesise principles of environmental and economic sustainability when solving problems;
6
effectively communicate knowledge, skills and ideas and work collaboratively in global team settings;
7
adapt to and adopt appropriate ethical, cultural and social principles in global medicines development;
8
demonstrate mastery in a specific professional development topic, such as entrepreneurism, global leadership or global pharma management.

Entry requirements

English language

Monash Level A, that is: IELTS (Academic): 6.5 overall (no band lower than 6.0); or Pearson Test of English (Academic): score of 58 overall with no band lower than 50; or TOEFL Internet-based test: score of 79 overall with minimum scores: Writing: 21, Listening: 12, Reading: 13 and Speaking: 18; or Equivalent approved English test

More information

Progression to further studies

Successful completion of this course may provide a pathway to a graduate research degree.

Other information

The Master of Global Medicines Development is a joint degree offered by Monash University and The University of North Carolina at Chapel Hill. This program provides you with a comprehensive understanding of how the discovery, development, and distribution of new medicines unfold on a global scale. In the units, taught collaboratively by academics across the two institutions, you will confront pressing issues such as funding medicines development in developing countries, navigating global drug regulations, and addressing disparities in access to appropriate medicines. By engaging with academics and your peers from around the world, you will develop leadership, data and financial management skills, and the cross-cultural understanding needed to work effectively in diverse teams. Through interdisciplinary coursework, team-based projects and a final semester placement opportunity, you will develop the expertise required to tackle pressing global challenges in the development of new medicines.

Contacts

Academic Coordinator: Dr Tony Hughes

Common questions

How long is Master of Global Medicines Development?

1.5 years full time, 72 credit points. At 24 credit points a semester, that is 3 semesters of full-time study.

Where can I study Master of Global Medicines Development?

At Parkville.

How do I plan my Master of Global Medicines Development units?

Open the course in the MonMap planner. It lays out your semesters, checks prerequisites as you drag units in, and tracks the credit points each requirement still needs.

Course details

Qualification: Master's Degree (Coursework)
AQF level: Level 9
Credit points: 72
Full time: 1.5 Years
Part time: 2.5 Years
Maximum time: 5 years

Faculty: Faculty of Pharmacy and Pharmaceutical Sciences
CRICOS code: 118224D
Abbreviation: MGlobalMedDev
Award title: Master of Global Medicines Development
Handbook years: 20262027